IS3827A - Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum - Google Patents

Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum

Info

Publication number
IS3827A
IS3827A IS3827A IS3827A IS3827A IS 3827 A IS3827 A IS 3827A IS 3827 A IS3827 A IS 3827A IS 3827 A IS3827 A IS 3827A IS 3827 A IS3827 A IS 3827A
Authority
IS
Iceland
Prior art keywords
pyridines
pyrrole
production
analogous method
analogous
Prior art date
Application number
IS3827A
Other languages
English (en)
Inventor
Briving Carin
Elebring Marie
Carlsson Stig
Carter Robert
Kühler Thomas
Nordberg Peter
Starke Ingemar
Svensson Arne
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of IS3827A publication Critical patent/IS3827A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS3827A 1991-03-27 1992-03-26 Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum IS3827A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100920A SE9100920D0 (sv) 1991-03-27 1991-03-27 New active compounds

Publications (1)

Publication Number Publication Date
IS3827A true IS3827A (is) 1992-09-28

Family

ID=20382295

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3827A IS3827A (is) 1991-03-27 1992-03-26 Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum

Country Status (30)

Country Link
US (1) US5439917A (is)
EP (2) EP0580616A1 (is)
JP (1) JP3122792B2 (is)
CN (1) CN1067892A (is)
AP (1) AP309A (is)
AT (1) ATE175672T1 (is)
AU (1) AU655634B2 (is)
BG (1) BG98124A (is)
CA (1) CA2106880A1 (is)
DE (1) DE69228142T2 (is)
DK (1) DK0509974T3 (is)
ES (1) ES2129039T3 (is)
FI (1) FI934203A7 (is)
GR (1) GR3029834T3 (is)
HU (1) HUT65948A (is)
IE (1) IE920915A1 (is)
IL (1) IL101347A0 (is)
IS (1) IS3827A (is)
JO (1) JO1704B1 (is)
MA (1) MA22477A1 (is)
MX (1) MX9201324A (is)
NO (1) NO933425L (is)
NZ (1) NZ241943A (is)
SE (1) SE9100920D0 (is)
SK (1) SK103093A3 (is)
TN (1) TNSN92026A1 (is)
TW (1) TW198032B (is)
WO (1) WO1992017477A1 (is)
YU (1) YU30292A (is)
ZA (1) ZA921823B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2001047922A2 (en) * 1999-12-24 2001-07-05 Aventis Pharma Limited Azaindoles
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
JP2005534618A (ja) * 2002-03-28 2005-11-17 エーザイ株式会社 神経変性疾患用の、c−junn−末端キナーゼ阻害剤としての7−アザインドール
AU2003254282A1 (en) * 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
GB0305142D0 (en) * 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
RS52908B (sr) 2003-03-10 2014-02-28 Takeda Gmbh Novi postupak za dobijanje roflumilasta
US6981980B2 (en) 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
WO2004101565A2 (en) * 2003-05-16 2004-11-25 Eisai Co., Ltd. Jnk inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds

Also Published As

Publication number Publication date
AP9200369A0 (en) 1992-04-30
EP0509974B1 (en) 1999-01-13
HUT65948A (en) 1994-08-29
EP0509974A1 (en) 1992-10-21
SE9100920D0 (sv) 1991-03-27
NO933425L (no) 1993-10-25
JPH06506448A (ja) 1994-07-21
TW198032B (is) 1993-01-11
NO933425D0 (no) 1993-09-24
BG98124A (bg) 1994-11-15
ZA921823B (en) 1992-11-25
AP309A (en) 1994-01-13
HU9302741D0 (en) 1993-12-28
US5439917A (en) 1995-08-08
MX9201324A (es) 1992-10-01
DK0509974T3 (da) 1999-08-30
FI934203L (fi) 1993-09-24
TNSN92026A1 (fr) 1993-06-08
EP0580616A1 (en) 1994-02-02
MA22477A1 (fr) 1992-10-01
CA2106880A1 (en) 1992-09-28
GR3029834T3 (en) 1999-06-30
WO1992017477A1 (en) 1992-10-15
IL101347A0 (en) 1992-11-15
JP3122792B2 (ja) 2001-01-09
AU655634B2 (en) 1995-01-05
ATE175672T1 (de) 1999-01-15
CN1067892A (zh) 1993-01-13
ES2129039T3 (es) 1999-06-01
JO1704B1 (en) 1992-12-15
YU30292A (sh) 1995-01-31
NZ241943A (en) 1993-12-23
FI934203A0 (fi) 1993-09-24
DE69228142D1 (de) 1999-02-25
DE69228142T2 (de) 1999-07-22
SK103093A3 (en) 1994-08-10
AU1426092A (en) 1992-11-02
FI934203A7 (fi) 1993-09-24
IE920915A1 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
IS4148A (is) Hliðstæð aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum
IS4121A (is) Hliðstæð aðferð til framleiðslu á 2,6-Díamínópúrín afleiðum
IS1867B (is) Hliðstæð aðferð til framleiðslu á kristölluðum oxaþíólan afleiðum
IS1708B (is) Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum
IS3915A (is) Aðferð til framleiðslu á benzanilíð afleiðum
IS3914A (is) Aðferð til framleiðslu á benzanilíð afleiðum
IS3970A (is) Hliðstæð aðferð til framleiðslu á 1,5-benzódíazepín afleiðum
IS4201A (is) Aðferð til framleiðslu á Benzofuran afleiðum
IS3994A (is) Hliðstæð aðferð til framleiðslu á indole afleiðum
IS3871A (is) Hliðstæðar aðferðir til framleiðslu á Quinuclidine afleiðum
TR27174A (tr) Vinilasetatin üretilmesine mahsus usul.
IS3827A (is) Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum
IS3954A (is) Hliðstæð aðferð við framleiðslu nýrra peptíðafleiða
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
ITTO920136A1 (it) Procedimento di produzione di organopolisilossani.
IS4219A (is) Aðferð til framleiðslu á Indole afleiðum
FI940769L (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI943703L (fi) Menetelmä gamma-butyrolaktonin valmistamiseksi
IS4190A (is) Hliðstæð aðferð til framleiðslu á 1,5 bensódíasepín afleiðum
FI913864L (fi) Produktionsprocess.
FI960332A7 (fi) Menetelmä substituoitujan 4,6-diamino-5-syanopyrinidiinien valmistamiseksi
NO904822L (no) Fremgangsmaate for fremstilling av pyridinderivater.
FI903088A0 (fi) Process foer framstaellning av straengsprutade skumkroppar.
FI910756A7 (fi) Fermentaatiomenetelmä staurosporiinin valmistamiseksi
ZA9110170B (en) Method for inhibiting IgE production.